Topical treatment for vitiligo brings remission of vitiligo and halo nevus in a girl: A case report

Authors

  • Delwar Hossain

DOI:

https://doi.org/10.66344/jpad.23.4.2013.326

Keywords:

Vitiligo, halo nevus, topical treatment

Abstract

Our patient had a halo nevus in the scalp and multiple patches of vitiligo elsewhere. Complete remission of her vitiligo and halo nevus was achieved with topical treatment for vitiligo without incurring any harm to the patient. 

References

Itin HP, Lautenschlager S. Acquired leukoderma in congenital pigmented nevus associated with vitiligo-like depigmentation. Pediatr Dermatol. 2002;19:73-5.

Dutta AK, Mandal SB. A clinical study of 650 vitiligo cases and their classification. Indian J Dermatol. 1969;14:103-11.

Frank SB, Cohen JH. The halo nevi. Archive Dermatol. 1964;89:367-73.

Wayte DM, Helwig EB. Halo nevi. Cancer. 1968;22:69-90.

Epstein WL, Sagebeil R, Spitler L et al. Halo nevi and melanoma. JAMA. 1973;225:373-7.

Kopf AW, Morril SD, Silberberg I. Broad spectrum of leukoderma acquisition centrifugum. Archive Dermatol. 1965;92:14-35.

Copeman PWM, Lewis MG, Elliott PG. Immunological associations of the halo naevus with cutaneous malignant melanoma. Br J Dermatol. 1973;88:127-37.

Parrish JA, Fitzpatrick TB, Shea C et al. Photochemotherapy of vitiligo. Arch Dermatol. 1976;112:1531-4.

Kumari J. Vitiligo treated with topical clobetasol propionate. Arch Dermatol. 1984;120:631-5.

Downloads

Published

2016-12-16

How to Cite

1.
Hossain D. Topical treatment for vitiligo brings remission of vitiligo and halo nevus in a girl: A case report. J Pak Assoc Dermatol [Internet]. 2016Dec.16 [cited 2026Apr.12];23(4):349-51. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/326

Issue

Vol. 23 No. 4 (2013): October - December

Section

Case Reports

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.